Vaxcyte files separate $500M offerings for equity/pre-funded warrants and 2032 convertible notes (PCVX:NASDAQ)
· seekingalpha.com
Vaxcyte (PCVX) launches $500M stock/warrant and $500M convertible notes offerings to fund VAX-31 trials, scale-up and U.S.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...